Advertisement
Advertisement
Trending on CancerNetwork
1
SLN Surgery Omission Does Not Increase Radiotherapy Use in Breast Cancer
2
135 Elacestrant in Combination With Everolimus or Abemaciclib in Patients With ER+/HER2– Locally Advanced or Metastatic Breast Cancer (mBC): Phase 2 Results From ELEVATE, an Open-Label, Umbrella Study
3
FDA Accepts Protocol Amendment to Phase 3 NANORAY-312 Trial in HNSCC
4
TIP134 ELECTRA: An Open-Label, Multicenter, Phase 1b/2 Study of Elacestrant in Combination With Abemaciclib in Patients With Brain Metastasis From ER+/HER2– Breast Cancer
5